SEC
SlamSEC
Search
Browse
Earnings
Third Harmonic Bio, Inc. — SlamSEC
Third Harmonic Bio, Inc.
Pharmaceutical Preparations
·
SAN FRANCISCO, CA
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Summary Financials
Revenue
—
Adj. EBITDA
-$43.9M
FY 2024
Net Income
-$30.8M
FY 2024
EPS (Diluted)
$0.78
FY 2024
Stock Price
—
52W Range
—
P/E Ratio
—
Market Cap
—
Cash
$269.1M
FY 2024
Total Debt
—
Net Cash
$269.1M
Enterprise Value
—
Debt / EBITDA
6.1x
FY 2024
EV / EBITDA
—
Employees
—